Targeting MYC effector functions in pancreatic cancer by inhibiting the ATPase RUVBL1/2.
Vogt M, Dudvarski Stankovic N, Cruz Garcia Y, Hofstetter J, Schneider K, Kuybu F, Hauck T, Adhikari B, Hamann A, Rocca Y, Grysczyk L, Martin B, Gebhardt-Wolf A, Wiegering A, Diefenbacher M, Gasteiger G, Knapp S, Saur D, Eilers M, Rosenfeldt M, Erhard F, Vos SM, Wolf E.
Vogt M, et al. Among authors: adhikari b.
Gut. 2024 May 31:gutjnl-2023-331519. doi: 10.1136/gutjnl-2023-331519. Online ahead of print.
Gut. 2024.
PMID: 38821858
Free article.